Streetbeat News

Insider Trading

LYFT

UBER

Lyft's stock is trading higher after the company disclosed insider buying activities. CEO Risher John David and Director Stephenson Dave bought shares at an average price of $11.46 and $11.33 per share respectively. Lyft reported Q2 revenue of $1.021 billion, up 3% YoY, and earnings per share of 16 cents, beating the Street consensus estimate. Unlike Uber, Lyft has not diversified beyond transportation and geography.

Portfolio Pulse from Anusuya Lahiri

August 15, 2023 | 6:04 pm

PI

Impinj, Inc.'s Director Daniel Patrick Gibson has purchased 263,740 shares at an average price of $58.26 per share, according to a Form 4 filing with the SEC.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 1:50 pm

CTV

EFSH

FTEK

VINC

Insiders at Innovid Corp. (CTV), Vincerx Pharma, Inc. (VINC), Fuel Tech, Inc. (FTEK), and 1847 Holdings LLC (EFSH) have recently acquired shares, indicating their confidence in the companies' prospects. Innovid and Vincerx posted better-than-expected sales and narrower losses respectively, while Fuel Tech and 1847 Holdings reported wider-than-expected losses.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 1:28 pm

LYFT

Lyft's Director, Dave Stephenson, has purchased 8,826 shares at an average price of $11.33 per share, according to a Form 4 filing with the SEC.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 1:19 pm

LYFT

Lyft's CEO, Risher John David, has purchased 100,000 shares of the company at an average price of $11.46 per share, according to a Form 4 filing with the SEC.

Portfolio Pulse from Happy Mohamed

August 15, 2023 | 1:18 pm

BOOT

DAR

DBX

LYB

Insiders at Dropbox, Darling Ingredients, LyondellBasell Industries, and Boot Barn Holdings have recently sold significant amounts of shares. Dropbox's CFO sold 75,000 shares, Darling Ingredients' EVP Chief Strategy Officer sold 28,734 shares, LyondellBasell's 10% owner sold 450,000 shares, and Boot Barn's Chief Retail Officer sold 10,250 shares. These sales could indicate concerns about the companies' prospects or that the insiders view the stocks as overpriced.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 12:37 pm

RCL

SGTX

SRPT

Insider trades were noted in three healthcare stocks: Royal Caribbean Cruises Ltd. (RCL), Sarepta Therapeutics, Inc. (SRPT), and Sigilon Therapeutics, Inc. (SGTX). RCL's director acquired 1,000 shares, indicating confidence in the company's prospects after reporting Q2 sales growth. SRPT's director acquired 23,686 shares following a narrower-than-expected Q2 loss. Shenandoah Acquisition Corp, a 10% owner of SGTX, bought 1,718,493 shares after Eli Lilly agreed to acquire the company.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 11:44 am

TGTX

TG Therapeutics' CEO and President, Michael Weiss, has purchased 100,000 shares of the company's stock at an average price of $10.13 per share. This has led to an increase in the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 4:31 pm

QRTEA

Michael Burry, through his 13F filing, has been revealed to hold 1.5 million shares of Qurate Retail (QRTEA).

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 4:11 pm

TGTX

TG Therapeutics' CEO and President, Michael Weiss, has purchased 100,000 shares of the company at an average price of $10.13 per share, according to a Form4 filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 2:00 pm